Solution structure of the human ubiquitin-specific protease 15 DUSP domain

被引:38
作者
de Jong, RN [1 ]
Ab, E [1 ]
Diercks, T [1 ]
Truffault, V [1 ]
Daniëls, M [1 ]
Kaptein, R [1 ]
Folkers, GE [1 ]
机构
[1] Univ Utrecht, Bijvoet Ctr Biomol Res, Dept NMR Spect, NL-3584 CH Utrecht, Netherlands
关键词
D O I
10.1074/jbc.M510993200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ubiquitin-specific proteases ( USPs) can remove covalently attached ubiquitin moieties from target proteins and regulate both the stability and ubiquitin-signaling state of their substrates. All USPs contain a conserved catalytic domain surrounded by one or more subdomains, some of which contribute to target recognition. One such specific subdomain, the DUSP domain ( domain present in ubiquitin-specific proteases), is present in at least seven different human USPs that regulate the stability of or interact with the hypoxia-inducible transcription factor HIF1-alpha, the Von Hippel-Lindau protein ( pVHL), cullin E3 ligases, and BRCA2. We describe the NMR solution structure of the DUSP domain of human USP15, recently implicated in COP9 ( constitutive photomorphogenic gene 9) -signalosome regulation. Its tripod-like structure consists of a 3-fold alpha-helical bundle supporting a triple-stranded anti-parallel alpha-sheet. The DUSP domain displays a novel fold, an alpha/beta tripod ( AB3). DUSP domain surface properties and previously described work suggest a potential role in protein/protein interaction or substrate recognition.
引用
收藏
页码:5026 / 5031
页数:6
相关论文
共 45 条
[1]   Mechanism and function of deubiquitinating enzymes [J].
Amerik, AY ;
Hochstrasser, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2004, 1695 (1-3) :189-207
[2]   Isolation and characterization of the mouse ubiquitin-specific protease Usp15 [J].
Angelats, C ;
Wang, XW ;
Jermiin, LS ;
Copeland, NG ;
Jenkins, NA ;
Baker, RT .
MAMMALIAN GENOME, 2003, 14 (01) :31-46
[3]   Identification, functional characterization, and chromosomal localization of USP15, a novel human ubiquitin-specific protease related to the UNP oncoprotein, and a systematic nomenclature for human ubiquitin-specific proteases [J].
Baker, RT ;
Wang, XW ;
Woollatt, E ;
White, JA ;
Sutherland, GR .
GENOMICS, 1999, 59 (03) :264-274
[4]   Distinct aerobic and hypoxic mechanisms of HIF-α regulation by CSN5 [J].
Bemis, L ;
Chan, DA ;
Finkielstein, CV ;
Qi, L ;
Sutphin, PD ;
Chen, XJ ;
Stenmark, K ;
Giaccia, AJ ;
Zundel, W .
GENES & DEVELOPMENT, 2004, 18 (07) :739-744
[5]   Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB [J].
Brummelkamp, TR ;
Nijman, SMB ;
Dirac, AMG ;
Bernards, R .
NATURE, 2003, 424 (6950) :797-801
[6]  
Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
[7]  
Cummins J.M., 2004, Nature, V428, P1, DOI [DOI 10.1038/NATURE02501, 10.1038/nature02501]
[8]   Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation [J].
Curcio-Morelli, C ;
Zavacki, AM ;
Christofollete, M ;
Gereben, B ;
de Freitas, BCG ;
Harney, JW ;
Li, ZB ;
Wu, G ;
Bianco, AC .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 112 (02) :189-196
[9]   von Hippel-Lindau tumor suppressor: not only HIF's executioner [J].
Czyzyk-Krzeska, MF ;
Meller, J .
TRENDS IN MOLECULAR MEDICINE, 2004, 10 (04) :146-149
[10]   An efficient strategy for assignment of cross-peaks in 3D heteronuclear NOESY experiments [J].
Diercks, T ;
Coles, M ;
Kessler, H .
JOURNAL OF BIOMOLECULAR NMR, 1999, 15 (02) :177-180